Copyright
©The Author(s) 2019.
World J Gastroenterol. Sep 28, 2019; 25(36): 5530-5542
Published online Sep 28, 2019. doi: 10.3748/wjg.v25.i36.5530
Published online Sep 28, 2019. doi: 10.3748/wjg.v25.i36.5530
Table 3 KRAS/GNAS mutations in cystic fluid and final diagnosis
| KRAS/GNAS mutations analysis in cystic fluid, n = 17 | Cancer | No cancer |
| Positive mutations (+) | ||
| Population size, n | 7 | 3 |
| Patient codes | True positive: 10, 13, 14, 15, 17, 18, 19 | False positive: 5, 6, 20 |
| Negative mutations (-) | ||
| Population size, n | 2 | 5 |
| Patient codes | False negative: 1, 9 | True negative: 2, 3, 4, 8, 16 |
| Total population, n | 9 | 8 |
- Citation: Laquière A, Lagarde A, Napoléon B, Bourdariat R, Atkinson A, Donatelli G, Pol B, Lecomte L, Curel L, Urena-Campos R, Helbert T, Valantin V, Mithieux F, Buono JP, Grandval P, Olschwang S. Genomic profile concordance between pancreatic cyst fluid and neoplastic tissue. World J Gastroenterol 2019; 25(36): 5530-5542
- URL: https://www.wjgnet.com/1007-9327/full/v25/i36/5530.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i36.5530